The global dialysis market size was US$ 97315.74 million in 2021. The global dialysis market size is forecast to reach US$ 174446.7 million by 2030, growing at a compound annual growth rate (CAGR) of 6.70% during the forecast period from 2022 to 2030.
Chronic renal failure patients may require dialysis to remove waste products from their blood, such as urea and creatinine because, of abnormal kidney function. The procedure is crucial during the treatment of end-stage renal disease (ESRD) and kidney transplantation. This procedure purifies the blood and removes excess fluid and toxins while rebalancing electrolytes. Hemodialysis and peritoneal dialysis are the two types of dialysis. Hemodialysis removes waste products such as urea from the patient's blood extracorporeally. Peritoneal dialysis uses the peritoneum in the abdomen for dialysis.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic affected the market moderately. COVID-19 infection is primarily a respiratory disease, but it can also affect the kidneys, causing acute renal infection (AKI). As a result of the lockdown, supply chain operations suffered, and consumables for peritoneal dialysis, hemodialysis, and essential medicines ran low, leading to a decrease in dialysis procedures performed at several dialysis centers. As a result of such adverse scenarios, the overall impact of the COVID-19 pandemic had substantial.
Regional Analysis
In 2021, Asia-Pacific generated the most revenue in the dialysis market. This is due to the high prevalence rate of diabetes and hypertension, the presence of a high disposable income, and the use of technologically advanced products. Additionally, there are many dialysis centers in this region, and an increase in the number of patients with chronic renal and kidney diseases should boost the market growth. In addition, the Asia-Pacific region is forecast to experience the highest CAGR during the analysis period, which is due to a rise in kidney failure incidence rates, a low rate of organ transplantation, and a rise in healthcare expenditures.
Leading Competitors
The leading prominent companies profiled in the global dialysis market are:
Scope of the Report
The global dialysis market segmentation focuses on Type, Products and Services, End-User, and Region.
Segmentation based on Type
Segmentation based on Products and Services
Segmentation based on End-User
Segmentation based on Region
[Table of Contents]
1 INTRODUCTION OF GLOBAL DIALYSIS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL DIALYSIS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL DIALYSIS MARKET, BY TECHNOLOGY
5.1 OVERVIEW
5.2 HEMODIALYSIS
5.2.1 CONVENTIONAL HEMODIALYSIS
5.2.2 SHORT DAILY HEMODIALYSIS
5.2.3 NOCTURNAL HEMODIALYSIS
5.3 PERITONEAL DIALYSIS
5.4 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)
5.5 AUTOMATED PERITONEAL DIALYSIS (APD)
6 GLOBAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES
6.1 EQUIPMENT
6.1.1 DIALYSIS MACHINES
6.1.2 WATER TREATMENT SYSTEMS
6.1.3 OTHERS DIALYSIS EQUIPMENT
6.2 CONSUMABLES
6.2.1 DIALYZERS
6.2.2 CATHETERS
6.2.3 OTHER DIALYSIS CONSUMABLES
6.3 DIALYSIS DRUGS
6.4 SERVICES
7 GLOBAL DIALYSIS MARKET, BY END-USER
7.1 IN-CENTER DIALYSIS
7.2 HOME DIALYSIS
8 GLOBAL DIALYSIS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3. 1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL DIALYSIS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
10 COMPANY PROFILES
10.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.2 BAXTER INTERNATIONAL INCORPORATED
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.3 NIPRO CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.4 B BRAUN MELSUNGEN AG
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.5 NIKKISO CO., LIMITED
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.6 BECTON, DICKINSON, AND COMPANY (C. R. BARD, INC.)
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.7 ANGIODYNAMICS INCORPORATED
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.8 ASAHI KASEI CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.9 DAVITA
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.10 DIAVERUM DEUTSCHLAND GMBH
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved